Sai Parenteral’s IPO Subscription Status Day 1

Here, the Sai Parenteral’s IPO launched on 24th March 2026. Bidding for the issue will close today, 27th March 2026. The primary aim of Sai Parenteral’s IPO is to raise ₹408.79 crores from the market. Also, the Sai Parenteral’s IPO has received an impressive level of subscription, indicating that the shares will be listed at an impeccable premium. Scroll down to check the Sai Parenteral’s IPO subscription and details. 

Sai Parenteral’s IPO Details 

The price band for the Sai Parenteral’s IPO has been set at ₹372 to ₹392 per share. Let’s segregate the share quota fixed for different categories of investors.

Sai Parenteral’s IPO Subscription Status

As of now, the Sai Parenteral’s IPO has been subscribed to 0.00 times. Of these, 0.00 times are subscribed by retail investors, 0.00 times by non-institutional investors, and 0.00 times by QII (Qualified Institutional Investors).  

The healthy subscription status indicates that investors are expecting higher returns at the time of Sai Parenteral’s IPO listing on 2nd April 2026. Sai Parenteral also has a positive outlook on the fresh issue of 1.77 crore shares, which will raise around Rs 1,100 crores.

Sai Parenteral’s IPO GMP Today

We know that higher subscription levels drive grey-market premiums for IPOs. Let’s explore the Sai Parenteral’s IPO GMP for 24th March 2026. 

The grey market premium for this IPO is flat at ₹0.00 per share. It indicates that the estimated listing price per share is Rs 392.00. Numerous factors played a pivotal role in this jump in Sai Parenteral’s GMP ahead of its IPO. These include higher subscription rates, favourable market sentiment, and investors’ positive attitude towards IPOs.

About Sai Parenteral’s Limited

Sai Parenteral’s Ltd. is a diversified pharmaceutical formulations company with expertise in research, development, and manufacturing. The company operates in two segments: Branded Generic Formulations and Contract Development and Manufacturing Organisation (CDMO) products and services for domestic and international markets. The product portfolio spans multiple therapeutic areas, including cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements (VMS), analgesics, and dermatology. Offerings are across dosage forms such as injectables, tablets, capsules, liquid orals, and ointments.

Sai Parenteral’s Limited Financials

The company’s financial analysis is essential before applying for Sai Parenteral’s IPO. See the table for Sai Parenteral’s Limited’s financials. 

Explanation

Sai Parenteral’s Limited’s revenue increased by 5%, from ₹10.99 crore in March 2024 to ₹14.17 crore in March 2025. Moreover, the company’s PAT increased by 4% from ₹2.39 crore in March 2024 to ₹2.52 crore in March 2025.

Technical Indicators

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Sai Parenteral’s IPO.

Sai Parenteral’s IPO Listing Expectations

Sai Parenteral’s IPO Highlights: IPO allotment is still pending, as the bid will close today. However, given the current GMP or market sentiment, it is reasonable to expect higher listing gains for the share. A flat 0.00% in Sai Parenteral’s, Highlight GMP suggests the estimated listing price per share will be around Rs. 392

It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ top long-term recommendation. 

Sai Parenteral’s IPO Dates

Note: IPO GMP is volatile and depends on market sentiment. Hence, one should conduct their research before investing in it.

Recent Articles

Central Mine Planning & Design Institute IPO GMP Day 2

Speciality Medicines GMP Day 2

Innovision IPO Listing Today

Novus Loyalty IPO GMP Day 3

Novus Loyalty IPO Subscription Status Day 3

Rajputana Stainless IPO Listing Preview

Innovision IPO Listing Preview

Central Mine Planning & Design Institute IPO GMP Day 1